Global News

Curetis initiates prospective multicenter Unyver study in Europe

Thursday, July 11, 2013 08:30 AM

Curetis has started an additional prospective, multicenter trial of its marketed Unyver P50 Pneumonia Application to demonstrate its clinical and health economic value.

More... »

Marken appoints general manager, China

Thursday, July 11, 2013 08:15 AM

Marken, a global clinical supply chain solutions provider, has appointed Joan Yan general manager for its Beijing office.  Yan will be responsible for the logistics operations in China and the new depot facility recently commissioned for the GMP storage and distribution of drug product and ancillary materials.

More... »

KJT Group names director of Health Outcomes

Wednesday, July 10, 2013 04:19 PM

KJT Group, a life sciences market research and insight consultancy firm, has named Arun Changolkar, Ph.D., M.B.A., director of Health Outcomes Research,  its life sciences research and consulting organization.

More... »

AstraZeneca inks cancer collaboration

Wednesday, July 10, 2013 12:27 PM

AstraZeneca has entered into an agreement with the University of Cambridge and Cancer Research U.K. for a two-year collaboration on three preclinical and clinical oncology projects. This agreement aims to advance cancer research through the study of tumor mutations and new investigational therapies in prostate, pancreatic and potentially other cancers.

More... »

Immunocore, GlaxoSmithKline sign research and licensing agreement

Wednesday, July 10, 2013 12:26 PM

Immunocore, an Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, has entered into a partnership with GlaxoSmithKline for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.

More... »

Blackfield signs fourth pharmaceutical partnership

Wednesday, July 10, 2013 12:09 PM

Germany-based researcher Blackfield is collaborating with AstraZeneca. Blackfield will apply its genomics technologies and computational biology capabilities to validate preclinical models to support one of AZ’s oncology drug development programs.

More... »

Greenphire, Ernst & Young form strategic partnership

Tuesday, July 9, 2013 03:08 PM

Greenphire, a provider of payment technologies for the clinical trials industry, has launched a strategic partnership with Ernst & Young (E&Y) to combine Greenphire’s eClinicalGPS technology with the global intellectual property and expertise of E&Y’s advisory practice for clients in the pharmaceutical industries.

More... »

Theorem partners with Emergo for regulatory consulting

Tuesday, July 9, 2013 03:06 PM

CRO Theorem Clinical Research, based in King of Prussia, Penn., has formed a strategic partnership with Emergo Group to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community. 

More... »

Neurocrine completes study enrollment

Tuesday, July 9, 2013 01:37 PM

Biopharmaceutical Neurocrine Biosciences has completed recruitment in the phase IIb clinical trial (Kinect Study) of its proprietary Vesicular Mono-Amine Transporter 2 compound, NBI-98854. The final subject will randomize this week.

More... »

Optibrium, AstraZeneca sign deal for global software license

Tuesday, July 9, 2013 11:29 AM

AstraZeneca has signed an agreement to license software developer Optibrium's StarDrop software. StarDrop and the ADME-QSAR and Auto-Modeller modules will be deployed globally to AstraZeneca's researchers.

More... »